80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]劉加夫,張宏英,陳曉紅,等.熒光ROSE在肺惡性腫瘤細(xì)胞學(xué)診斷中的應(yīng)用分析[J].福建醫(yī)藥雜志,2024,46(04):6-9.[doi:10.20148/j.fmj.2024.04.002]
　LIU Jiafu,ZHANG Hongying,CHEN Xiaohong,et al.Analysis of fluorescence ROSE in cytological diagnosis of lung malignant tumors[J].FUJIAN MEDICAL JOURNAL,2024,46(04):6-9.[doi:10.20148/j.fmj.2024.04.002]
點(diǎn)擊復(fù)制

熒光ROSE在肺惡性腫瘤細(xì)胞學(xué)診斷中的應(yīng)用分析()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
46
期數(shù):
2024年04期
頁碼:
6-9
欄目:
臨床研究
出版日期:
2024-08-15

文章信息/Info

Title:
Analysis of fluorescence ROSE in cytological diagnosis of lung malignant tumors
文章編號(hào):
1002-2600(2024)04-0006-04
作者:
劉加夫; 張宏英; 陳曉紅; 林清華; 陳友軒; 吳聯(lián)平; 林玉瓊; 黃小紅
福建省福州肺科醫(yī)院,福州 350008
Author(s):
LIU Jiafu; ZHANG Hongying; CHEN Xiaohong; LIN Qinghua; CHEN Youxuan; WU Lianping; LIN Yuqiong; HUANG Xiaohong
Fuzhou Pulmonary Hospital,Fuzhou,Fujian 350008,China
關(guān)鍵詞:
熒光細(xì)胞學(xué)現(xiàn)場快速評(píng)估;  惡性腫瘤;  CT引導(dǎo)經(jīng)皮肺活檢;  細(xì)胞學(xué)
Keywords:
fluorescence cytology rapid on-site evaluation;  malignant tumor;  CT-guided percutaneous lung biopsy;  cytology
分類號(hào):
R734
DOI:
10.20148/j.fmj.2024.04.002
文獻(xiàn)標(biāo)志碼:
B
摘要:
目的 探討在CT引導(dǎo)經(jīng)皮肺活檢(PTLB)聯(lián)合熒光細(xì)胞學(xué)現(xiàn)場快速評(píng)估(F-rose)在肺惡性腫瘤細(xì)胞學(xué)診斷中的應(yīng)用價(jià)值。方法 收集在我院進(jìn)行的微創(chuàng)CT引導(dǎo)下經(jīng)皮肺穿刺活檢的住院患者120例。在CT引導(dǎo)定位下對(duì)病變區(qū)域細(xì)針穿刺取材,將穿刺針殘留液涂至兩張載玻片上,并分別用另兩張清潔載玻片疊放、輕壓,反向勻速拉開,制成4張涂片,迅速放置于95%酒精中固定后取出干燥。通過熒光ROSE染色和ROSE染色來評(píng)估兩種染色方法在肺部占位性病變中的差異性。根據(jù)組織病理學(xué)結(jié)果明確病理診斷篩選出94例患者,其中確診惡性腫瘤66例,非腫瘤性病變28例。患者以真菌和抗酸分枝桿菌陽性為非腫瘤性病變患者。以病理組織學(xué)結(jié)果為金標(biāo)準(zhǔn),分析兩種方法對(duì)肺惡性腫瘤細(xì)胞學(xué)診斷的靈敏度及特異度,并評(píng)估兩種方法對(duì)肺惡性腫瘤的細(xì)胞學(xué)診斷價(jià)值差異性。結(jié)果 熒光ROSE和ROSE組的總確診率分別為60.64%和48.94%(P<0.05); 診斷肺部惡性腫瘤的靈敏度兩組均為68.18%(P>0.05); 熒光ROSE和ROSE組的特異度分別為42.86%、3.57%(P<0.05)。結(jié)論 熒光ROSE聯(lián)合PTLB可提高肺部占位性病變的確診率,尤其可提高肺部惡性腫瘤細(xì)胞學(xué)診斷的特異度,在肺部占位性病變細(xì)胞學(xué)診斷中具有一定臨床應(yīng)用價(jià)值。
Abstract:
Objective To explore the clinical application of CT-guided percutaneous lung biopsy(PTLB)combined with fluorescence cytology rapid on-site evaluation(F-rose)in the cytological diagnosis of lung malignant tumors. Methods One hundred and twenty hospitalized patients who underwent minimally invasive CT-guided percutaneous lung puncture biopsy in our hospital were collected. Under CT-guided localization of the lesion area fine-needle puncture sampling,the puncture needle residual fluid was applied to two slides,and respectively,the other two clean slides were stacked,lightly pressed,and pulled apart at a uniform speed in the reverse direction to make four smears,which were quickly placed in 95% alcohol for fixation and then removed for drying. Differences between the two staining methods in lung occupying lesions were evaluated by fluorescent ROSE staining and ROSE staining. Ninety-four patients were screened for definitive pathological diagnosis based on histopathological findings,of which 66 were confirmed malignant tumors and 28 were non-neoplastic lesions.Patients with fungal and Mycobacterium antacidum-positive is non-neoplastic lesions. The sensitivity and specificity of the two methods for the cytological diagnosis of lung malignant tumors were analyzed using the pathohistological results as the gold standard,and the differences in the cytological diagnostic value of the two methods for lung malignant tumors were evaluated. Results The overall confirmed diagnosis rates of fluorescent ROSE and ROSE groups were 60.64% and 48.94% respectively(P<0.05); the sensitivity of diagnosing lung malignant tumors was 68.18% in both groups(P>0.05); and the specificity of the fluorescent ROSE and ROSE groups were 42.86% and 3.57%(P<0.05),respectively. Conclusion Fluorescence ROSE combined with PTLB can improve the confirmation rate of lung occupying lesions,especially the specificity of cytological diagnosis of lung malignant tumors,which has certain clinical application value in the cytological diagnosis of lung occupying lesions.

參考文獻(xiàn)/References:

[1] JAIN D,ALLEN T C,AISNER D L,et al. Rapid onsite evaluation of endobronchial ultrasoundguided transbronchial needle aspirations for the diagnosis of lung cancer: a perspective from members of the pulmonary pathology society[J].Arch Pathol Lab Med,2018,142(2):253262.
[2] 辛紅梅,仇紅.CT引導(dǎo)下經(jīng)皮肺穿刺活檢術(shù)在肺腫瘤定性診斷中的應(yīng)用[J].中國醫(yī)藥導(dǎo)報(bào),2013,10(10):104-106.
[3] 周任遠(yuǎn),何家揚(yáng).尿脫落細(xì)胞熒光試劑染色診斷膀胱移行細(xì)胞癌的意義[J].現(xiàn)代泌尿外科雜志,2003,8(3):142-144.
[4] 王劍,宋嘉,陳清勇.熒光快速現(xiàn)場評(píng)價(jià)在惡性胸膜疾病診斷中的應(yīng)用[J].浙江中西醫(yī)結(jié)合雜志,2021,31(10):925-928.
[5] 張敬,邢春燕,王欣.細(xì)胞學(xué)快速現(xiàn)場評(píng)價(jià)技術(shù)聯(lián)合纖維支氣管鏡檢查在肺占位性疾病診斷中的應(yīng)用[J].山東醫(yī)藥,2020(35):60.
[6] 田智丹,常立功,王糧,等.ROSE在肺部病變活檢病理診斷中的價(jià)值[J].南京醫(yī)科大學(xué)學(xué)報(bào):自然科學(xué)版,2020(11):5.
[7] 李燕,蔡后榮,演欣,等.快速現(xiàn)場評(píng)價(jià)技術(shù)在肺占位病變良惡性判斷中的作用[J].中國呼吸與危重監(jiān)護(hù)雜志,2018,17(5):4.
[8] 楊二樂. CT引導(dǎo)下經(jīng)皮肺穿刺活檢術(shù)在肺腫瘤定性診斷中的應(yīng)用價(jià)值[J].世界最新醫(yī)學(xué)信息文摘,2019,19(48):101.

相似文獻(xiàn)/References:

[1]林樹春 胡曉華 賴海春 林 勤.頭頸部鱗狀細(xì)胞癌患者體內(nèi)免疫抑制性細(xì)胞因子與調(diào)節(jié)性T細(xì)胞的表達(dá)分析[J].福建醫(yī)藥雜志,2020,42(03):23.
　LIN Shuchun,HU Xiaohua,LAI Haichun,et al.Analysis of expression of immunosuppressive cytokines and regulatory T cells in patients with head and neck squamous cell carcinoma[J].FUJIAN MEDICAL JOURNAL,2020,42(04):23.
[2]葉 彥,任 飛 綜述 黃慧恒 審校.血清NTx和ICTP在惡性腫瘤骨轉(zhuǎn)移中的臨床意義[J].福建醫(yī)藥雜志,2021,43(02):153.
[3]林康昵.腫瘤重癥監(jiān)護(hù)室膿毒癥患者預(yù)后影響因素分析[J].福建醫(yī)藥雜志,2024,46(05):14.[doi:10.20148/j.fmj.2024.05.004]
　LIN Kangni.Risk factors for sepsis patients with malignant tumor in intensive care unit[J].FUJIAN MEDICAL JOURNAL,2024,46(04):14.[doi:10.20148/j.fmj.2024.05.004]

備注/Memo

備注/Memo:
基金項(xiàng)目:福州市科技局市級(jí)科技計(jì)劃項(xiàng)目(2021-S-255)
更新日期/Last Update: 2024-08-15